Afamelanotide

Chemical formula: C₇₈H₁₁₁N₂₁O₁₉  Molecular mass: 1,646.845 g/mol  PubChem compound: 16197727

Therapeutic indications

Afamelanotide is indicated for:

Prevention of phototoxicity in erythropoietic protoporphyria (EPP)

Population group: only adults (18 - 65 years old)

Afamelanotide is indicated for prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Afamelanotide is contraindicated in the following cases:

Renal impairment

Renal failure

Hepatic impairment

Hepatic insufficiency

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2020: SCENESSE Implant
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈